Hepatitis B surface antigen (HBsAg) prevalence in Israel
Israel: Hepatitis B surface antigen (HBsAg) prevalence was 0.1% in 2024. ◆ Volatile
Latest (2024)
0.1%
Change on year
unchanged
World rank
101st
of 194 countries
All-time high
0.4%
in 2015
All-time low
0.1%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Israel, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Israel is 0.1%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 75.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Israel peaked at 0.4% in 2015 and was at its lowest, 0.1%, in 2020.
That places Israel 101st out of 194 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Hepatitis B surface antigen (HBsAg) prevalence in Israel, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.3% | -25.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.2% | -33.3% |
| 2019 | 0.2% | +0.0% |
| 2020 | 0.1% | -50.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.4% | 5 |
| 2020s | 0.1% | 0.1% | 0.1% | 5 |
Countries ranked near Israel
- 101 Singapore 0.1% compare
- 101 Serbia 0.1% compare
- 101 Thailand 0.1% compare
- 101 Trinidad and Tobago 0.1% compare
- 101 Tunisia 0.1% compare
- 101 Ukraine 0.1% compare
- 101 Uzbekistan 0.1% compare
- 101 Albania 0.1% compare
- 101 Armenia 0.1% compare
- 101 Australia 0.1% compare
- 101 Belize 0.1% compare
- 101 Bolivia, Plurinational State of 0.1% compare
- 101 Bhutan 0.1% compare
- 101 China 0.1% compare
- 101 Denmark 0.1% compare
- 101 Dominican Republic 0.1% compare
- 101 Algeria 0.1% compare
- 101 Gambia 0.1% compare
- 101 Guyana 0.1% compare
- 101 Hungary 0.1% compare
- 101 Jordan 0.1% compare
- 101 Kyrgyzstan 0.1% compare
- 101 Lebanon 0.1% compare
- 101 Lithuania 0.1% compare
- 101 Malaysia 0.1% compare
- 101 Oman 0.1% compare
- 101 Peru 0.1% compare
- 101 Paraguay 0.1% compare
- 101 Romania 0.1% compare
- 101 Russian Federation 0.1% compare
More health data for Israel
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6956 % change on previous year (2090)
- Heat deaths vs projected death rates 665.9 (2090)
- Un projection of annual infant deaths 119 (2100)
- Population ages 15-64, male, annual growth rate 1.48 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.3019 units per person (2025)
- Population ages 15-64, total, annual growth rate 1.39 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.6014 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Israel?
- Hepatitis b surface antigen (hbsag) prevalence in Israel was 0.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Israel?
- The highest recorded value was 0.4% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Israel?
- The lowest recorded value was 0.1% in 2020.
- How does Israel rank for hepatitis b surface antigen (hbsag) prevalence?
- Israel ranks 101st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Israel?
- Over the last ten years it is down 75.0%. The long-run trend across the full record is volatile.
- Where does this Israel data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).